ClinicalTrials.Veeva

Menu

Optimization of a Photoretinoscopy Method for Determining the Objective Refraction of Children With a Smartphone/add-on Device in India

E

Essilor

Status

Completed

Conditions

Ametropia

Treatments

Device: Comparator device, Closed-field autorefractometer with cycloplegia
Other: Distance visual acuity check using objective refraction with cycloplegia
Other: Distance visual acuity check using objective refraction without cycloplegia
Device: Comparator device, Closed-field autorefractometer without cycloplegia

Study type

Interventional

Funder types

Industry

Identifiers

NCT06524115
WS10364

Details and patient eligibility

About

The objective is to compare the refractive parameters of the photorefraction prototype device without cycloplegia with the refractive parameters of reference device, an autorefractometer with and without cycloplegia.

Full description

A single visit will be necessary. After informed consent, and checking of the inclusion and exclusion criteria, investigators will perform measurements with an autorefractometer and with the photorefraction prototype device without cycloplegia followed by an objective refraction with an autorefractometer under cyclopegia.

Enrollment

122 patients

Sex

All

Ages

6 to 13 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Voluntary, willing to follow the protocol, able to read and understand the information form and give free and informed consent (for parents/guardian of children subjects) and assent (for subjects aged 6-12 years old
  • At least 6 years old and up to 12 years old at time of informed consent and assent
  • Average of the equivalent sphere(Sph+Cyl/2) of both eye included in the interval [-10.00, +8.00]
  • Cylindrical refractive error between 0 and 4.00 D on both eyes
  • Corrected binocular visual acuity in distance vision at least 6/9

Exclusion criteria

  • Incapable of expressing consent
  • All categories of persons particularly protected by law
  • Subject in another study which might have an influence on vision or interfere with study assessment
  • Less than 6 years old, or 13 years old or above at time of informed consent and assent
  • Amblyopia, Cataract, Strabismus.
  • Aphakic or pseudophakic (intraocular implant)
  • Reported severe eye disease involving loss of visual field as in glaucoma, involving loss of acuity and severe discomfort in low or overly bright environments as in retinitis pigmentosa or reported and treated dry eye.
  • Self-reported neurological deficits, including a history of epileptic pathology or sensory-motor coordination disorders, vestibular or cerebellar pathology (e.g., balance disorders, nystagmus)
  • Any previous ocular surgery, which might have an influence on vision or interfere with study assessments (e.g. iridectomy, refractive surgery...),
  • Any myopia control solutions that could affect refractive status of the eye (e.g. Atropine eye drops, Orthokeratology)

Trial design

Primary purpose

Screening

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

122 participants in 1 patient group

Photorefraction prototype device
Experimental group
Description:
- Photoretinoscopic images without cycloplegia
Treatment:
Device: Comparator device, Closed-field autorefractometer without cycloplegia
Other: Distance visual acuity check using objective refraction without cycloplegia
Other: Distance visual acuity check using objective refraction with cycloplegia
Device: Comparator device, Closed-field autorefractometer with cycloplegia

Trial contacts and locations

1

Loading...

Central trial contact

Julien Andoche; Marie-Anne BERTHEZENE

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems